A year ago, a twelve-year-old girl became the youngest person in Canada undergo surgery to receive a total artificial heart. The device, which can essentially replace an entire human heart for a limited period of time, has only been used fifty-eight times in Canada to date.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transplantation - Heart
June 30, 2022
In January 2022, University of Maryland School of Medicine surgeon-scientists made history by successfully implanting a genetically modified pig heart into a fifty-seven-year-old patient in end-stage heart failure who did not qualify for a traditional heart transplant.
January 11, 2022
On January 10, 2021, the University of Maryland School of Medicine annnounced that Dr. Bartley P. Griffith and his team successfully transplanted a genetically modified pig heart in a 57-year-old man with end-stage heart failure, and the patient was doing well three days later.
January 11, 2022
On January 10, 2021, the University of Maryland School of Medicine annnounced that Dr. Bartley P.
April 28, 2021
This study assessed the impact of frailty in patients with advanced heart failure on clinical outcomes after heart transplantation (HTx).
April 16, 2020
The UNOS donor heart allocation system was revised in 2018, giving priority to patients on inpatient mechanical circulatory support (MCS). Patients admitted with heart failure-associated cardiogenic shock were tracked for the frequency of use of mechanical circulatory support before and after implementation of this change. In non-transplant center
April 2, 2020
Quite refreshing well-written experimental paper leaving promises of artificial organoids.
August 23, 2019
Excellent and brief summary of the debate on functional mitral regurgitation on mechanical support.
August 13, 2019
The translational value for cardiac transplantation of this prospective multi-centre clinical study of vasodilation in amyloidosis remains to be evaluated.
June 4, 2019
Left ventricular ejection fraction was not a predictor of outcomes after heart transplant, and was normal in all recipients at 1 year posttransplant. The reliance on generic transthoracic echocardiography for donor assessment may well be the Achilles heel of this retrospective case study.